---
figid: PMC4957946__nihms514432f1
figlink: /pmc/articles/PMC4957946/figure/F1/
number: F1
caption: mTOR is a serine/threonine kinase that regulates protein synthesis necessary
  for cell growth, proliferation, metabolism and angiogenesis. The binding of growth
  factors to cell surface receptors, such as VEGFr, IGF-receptor (IGF-1r) and EGFr,
  and by nutrients (amino acids and glucose) entering the cell, subsequently stimulate
  the mTOR signaling pathway. Key upstream elements include PI3K and AKT involved
  in the phosphorylation and activation of mTOR. Intracellular kinase PI3K synthesizes
  membrane phospholipids responsible for activation of the kinase AKT while negative
  regulator PTEN reverses PI3K activity and suppresses AKT activation. Activation
  of AKT facilitates phosphorylation of the tuberous sclerosis tumor suppressor gene
  TSC2 and leads to inactivation the TSC1-2 complex, a key regulator of mTORC1. mTORC1
  controls essential signal transduction pathways via its downstream effectors S6K1
  and 4E-BP1 and coordinates the production of the transcription factor HIF-1α. Promotion
  of transcription of angiogenic factors such as VEGF is regulated by HIF-1α in complex
  with HIF-1β. Dysregulation of the PI3K/AKT/mTOR pathway is observed in many cancers.
  A number of mechanisms are responsible for hyperactive mTOR signaling including
  overexpression or activation of growth factor receptors, activation of mutations
  in PI3K/AKT and decreased expression of PTEN, TSC1–2 or VHL. In this figure, activation
  is depicted as an arrow while inhibition is represented as a bar.4E-BP1, 4E-binding
  protein 1; HIF-1α, hypoxia-inducible factor-1α; mTOR, mammalian target of rapamycin;
  mTORC1, mTOR complex 1; PTEN, phosphatase and tensin homolog; S6K1, S6 kinase 1;
  TSC, tuberous sclerosis complex; VHL, von Hippel-Lindau. Republished with permission
  of Informa UK, Ltd., from Research and innovation in the development of everolimus
  for oncology, Lebwohl D, Thomas G, Lane HA, et al, Expert Opinions on Drug Discovery,
  Vol. 6, No. 3:323–338, 2011; permission conveyed through Copyright Clearance Center,
  Inc.
pmcid: PMC4957946
papertitle: Differentiating mTOR Inhibitors in Renal Cell Carcinoma.
reftext: Sumanta K. Pal, et al. Cancer Treat Rev. ;39(7):709-719.
pmc_ranked_result_index: '19056'
pathway_score: 0.9541931
filename: nihms514432f1.jpg
figtitle: Differentiating mTOR Inhibitors in Renal Cell Carcinoma
year: ''
organisms:
- Homo sapiens
ndex: ca0630f9-deed-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4957946__nihms514432f1.html
  '@type': Dataset
  description: mTOR is a serine/threonine kinase that regulates protein synthesis
    necessary for cell growth, proliferation, metabolism and angiogenesis. The binding
    of growth factors to cell surface receptors, such as VEGFr, IGF-receptor (IGF-1r)
    and EGFr, and by nutrients (amino acids and glucose) entering the cell, subsequently
    stimulate the mTOR signaling pathway. Key upstream elements include PI3K and AKT
    involved in the phosphorylation and activation of mTOR. Intracellular kinase PI3K
    synthesizes membrane phospholipids responsible for activation of the kinase AKT
    while negative regulator PTEN reverses PI3K activity and suppresses AKT activation.
    Activation of AKT facilitates phosphorylation of the tuberous sclerosis tumor
    suppressor gene TSC2 and leads to inactivation the TSC1-2 complex, a key regulator
    of mTORC1. mTORC1 controls essential signal transduction pathways via its downstream
    effectors S6K1 and 4E-BP1 and coordinates the production of the transcription
    factor HIF-1α. Promotion of transcription of angiogenic factors such as VEGF is
    regulated by HIF-1α in complex with HIF-1β. Dysregulation of the PI3K/AKT/mTOR
    pathway is observed in many cancers. A number of mechanisms are responsible for
    hyperactive mTOR signaling including overexpression or activation of growth factor
    receptors, activation of mutations in PI3K/AKT and decreased expression of PTEN,
    TSC1–2 or VHL. In this figure, activation is depicted as an arrow while inhibition
    is represented as a bar.4E-BP1, 4E-binding protein 1; HIF-1α, hypoxia-inducible
    factor-1α; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; PTEN,
    phosphatase and tensin homolog; S6K1, S6 kinase 1; TSC, tuberous sclerosis complex;
    VHL, von Hippel-Lindau. Republished with permission of Informa UK, Ltd., from
    Research and innovation in the development of everolimus for oncology, Lebwohl
    D, Thomas G, Lane HA, et al, Expert Opinions on Drug Discovery, Vol. 6, No. 3:323–338,
    2011; permission conveyed through Copyright Clearance Center, Inc.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - RPTOR
  - VEGFB
  - PIK3CA
  - VEGFD
  - VEGFA
  - IGF1
  - AKT1S1
  - PTEN
  - PGF
  - PIK3R3
  - DDIT4
  - RHEB
  - RRAGA
  - FLT1
  - PIK3R4
  - TSC1
  - TSC2
  - PRKAG3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - VEGFC
  - MTOR
  - FLT4
  - KDR
  - HIF1A
  - ARNT
  - MAPKAP1
  - EIF4EBP1
  - AKT3
  - STK11
  - MLST8
  - PRKAB2
  - RICTOR
  - PDCD4
  - VHL
  - ERBB2
  - RPS6KB1
  - PIK3R5
  - EEF2K
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PRKAG2
  - EGF
  - PRKAG1
  - AKT1
  - PIK3R6
  - PDK1
  - AKT2
  - EGFR
  - Glucose
  - Cancer
  - Lung cancer
genes:
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: REDD1
  symbol: REDD-1
  source: hgnc_alias_symbol
  hgnc_symbol: DDIT4
  entrez: '54541'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: RagA/B
  symbol: RAGA
  source: hgnc_alias_symbol
  hgnc_symbol: RRAGA
  entrez: '10670'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: HIF-1a
  symbol: HIF-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF-1B
  symbol: HIF-1beta
  source: hgnc_alias_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: SIN1
  symbol: SIN1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: MLST8
  symbol: MLST8
  source: hgnc_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PDCD4
  symbol: PDCD4
  source: hgnc_symbol
  hgnc_symbol: PDCD4
  entrez: '27250'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: EEF2K
  symbol: EEF2K
  source: hgnc_symbol
  hgnc_symbol: EEF2K
  entrez: '29904'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4957946__F1
redirect_from: /figures/PMC4957946__F1
figtype: Figure
---
